Search Within

Rachael Rose Parisi

Formats
  1. Meeting Abstract (3)
  2. Journal Article (2)
  3. Research Letter (1)
Groups
  1. Department of Medicine (5)
  2. Dermatology (5)
  3. Dermatology Service (5)
  4. Division of Subspecialty Medicine (5)
  5. Survivorship Research (5)
  6. Adult Leukemia (4)

More Groups

People
  1. Alina Markova (4)
  2. Emily Cowen (3)
  3. Melissa Pulitzer (3)
  4. Stephen Dusza (3)
  5. Amber King (2)
  6. Haoling Zhu (2)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (1)
  4. 2022 (3)
Publications
  1. Journal of the American Academy of Dermatology (2)
  2. Blood (1)
  3. JTO Clinical and Research Reports (1)
  4. Leukemia Research (1)
  5. Leukemia and Lymphoma (1)
Publishers
  1. Mosby Elsevier (2)
  2. American Society of Hematology (1)
  3. Elsevier BV (1)
  4. Elsevier Ltd (1)
  5. Taylor & Francis Group (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mucocutaneous adverse events in patients with cancer treated with the highly selective RET kinase inhibitor selpercatinib (LOXO-292)
    Journal Article

    Reingold, R. E.; Parisi, R.; Harada, G.; Moy, A. P.; Dranitsaris, G.; Francis, J. H.; Canestraro, J.; Lester, J. A.; Kaplanis, L. A.; Liu, D.; more...
    JTO Clinical and Research Reports (2025)

    Fulltext@MSK | Save
  • Dermatologic adverse events following CD19-directed CAR T-cell therapy in hematologic malignancies
    Meeting Abstract

    Storgard, R.; Reingold, R.; Parisi, R.; Dusza, S.; Noor, S.; Park, J.; Sauter, C.; Curran, K.; Perales, M.; Scordo, M.; more...
    Journal of the American Academy of Dermatology (2024)

    Fulltext@MSK | Save
  • Dermatologic adverse events in acute lymphocytic leukemia patients treated with bispecific T-cell engager blinatumomab
    Research Letter

    Parisi, R.; Cowen, E. A.; Gu, S.; Dusza, S.; Pulitzer, M.; Geyer, M. B.; King, A. C.; Markova, A.
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Dermatologic adverse events in acute lymphocytic leukemia patients treated with bispecific T-cell engager blinatumomab
    Meeting Abstract

    Parisi, R.; Cowen, E. A.; Gu, S.; Pulitzer, M.; Geyer, M. B.; King, A. C.; Markova, A.
    Blood (2022)

    Fulltext@MSK | Save
  • Dermatologic adverse events associated with IDH inhibitors ivosidenib and enasidenib for the treatment of acute myeloid leukemia
    Journal Article

    Parisi, R.; Cowen, E. A.; Stoll, J. R.; Zhu, H.; Dusza, S.; Pulitzer, M. P.; Stein, E. M.; Markova, A.
    Leukemia Research (2022)

    Fulltext@MSK | Save
  • Dermatologic adverse events in acute myeloid leukemia patients treated with IDH inhibitors ivosidenib and enasidenib
    Meeting Abstract

    Parisi, R.; Stoll, J.; Zhu, H.
    Journal of the American Academy of Dermatology (2022)

    Fulltext@MSK | Save